Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of EUR 287.43 billion. The enterprise value is 297.78 billion.

Market Cap	287.43B
Enterprise Value	297.78B

Important Dates

The next estimated earnings date is Wednesday, August 6, 2025.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

Current Share Class	3.36B
Shares Outstanding	n/a
Shares Change (YoY)	-0.61%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	3.18B

Valuation Ratios

The trailing PE ratio is 20.50 and the forward PE ratio is 17.96.

PE Ratio	20.50
Forward PE	17.96
PS Ratio	7.07
PB Ratio	15.48
P/TBV Ratio	73.53
P/FCF Ratio	27.10
P/OCF Ratio	16.34
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.15, with an EV/FCF ratio of 28.07.

EV / Earnings	21.23
EV / Sales	7.32
EV / EBITDA	14.15
EV / EBIT	15.12
EV / FCF	28.07

Financial Position

The company has a current ratio of 0.74, with a Debt / Equity ratio of 0.86.

Current Ratio	0.74
Quick Ratio	0.54
Debt / Equity	0.86
Debt / EBITDA	0.76
Debt / FCF	1.50
Interest Coverage	41.95

Financial Efficiency

Return on equity (ROE) is 88.12% and return on invested capital (ROIC) is 47.91%.

Return on Equity (ROE)	88.12%
Return on Assets (ROA)	23.29%
Return on Invested Capital (ROIC)	47.91%
Return on Capital Employed (ROCE)	58.02%
Revenue Per Employee	524,983
Profits Per Employee	181,173
Employee Count	77,349
Asset Turnover	0.77
Inventory Turnover	1.22

Taxes

In the past 12 months, Novo Nordisk has paid 3.71 billion in taxes.

Income Tax	3.71B
Effective Tax Rate	20.93%

Stock Price Statistics

The stock price has decreased by -56.43% in the last 52 weeks. The beta is 0.22, so Novo Nordisk's price volatility has been lower than the market average.

Beta (5Y)	0.22
52-Week Price Change	-56.43%
50-Day Moving Average	60.89
200-Day Moving Average	83.10
Relative Strength Index (RSI)	39.28
Average Volume (20 Days)	209,195

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of EUR 40.64 billion and earned 14.02 billion in profits. Earnings per share was 3.15.

Revenue	40.64B
Gross Profit	34.40B
Operating Income	19.68B
Pretax Income	17.74B
Net Income	14.02B
EBITDA	20.82B
EBIT	19.68B
Earnings Per Share (EPS)	3.15

Full Income Statement

Balance Sheet

The company has 5.57 billion in cash and 15.92 billion in debt, giving a net cash position of -10.35 billion.

Cash & Cash Equivalents	5.57B
Total Debt	15.92B
Net Cash	-10.35B
Net Cash Per Share	n/a
Equity (Book Value)	18.57B
Book Value Per Share	4.18
Working Capital	-8.27B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.59 billion and capital expenditures -6.99 billion, giving a free cash flow of 10.61 billion.

Operating Cash Flow	17.59B
Capital Expenditures	-6.99B
Free Cash Flow	10.61B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 84.65%, with operating and profit margins of 48.43% and 34.51%.

Gross Margin	84.65%
Operating Margin	48.43%
Pretax Margin	43.65%
Profit Margin	34.51%
EBITDA Margin	51.23%
EBIT Margin	48.43%
FCF Margin	26.10%

Dividends & Yields

This stock pays an annual dividend of 1.53, which amounts to a dividend yield of 2.61%.

Dividend Per Share	1.53
Dividend Yield	2.61%
Dividend Growth (YoY)	21.20%
Years of Dividend Growth	5
Payout Ratio	48.61%
Buyback Yield	0.61%
Shareholder Yield	3.22%
Earnings Yield	4.88%
FCF Yield	3.69%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 7.88 and a Piotroski F-Score of 5.

Altman Z-Score	7.88
Piotroski F-Score	5